The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
Open accessAbstract
The immune system is guided by a series of checks and balances, a major component of which is a large array of co-stimulatory and co-inhibitory pathways that modulate the host response. While co-stimulation is essential to boost and shape the initial response following signaling through the antigen receptor, inhibitory pathways are also critical to modulate the immune response. Excessive co-stimulation and/or insufficient co-inhibition can lead to a breakdown of self-tolerance, leading to autoimmunity. In this review, we will focus on the role of co-stimulatory and co-inhibitory pathways in two systemic (Systemic Lupus Erythematosus and Rheumatoid Arthritis) and two organ-specific (Multiple Sclerosis and Type 1 Diabetes) autoimmune diseases that are emblematic. We will also discuss how mechanistic analysis of these pathways has led to the identification of potential therapeutic targets and initiation of clinical trials for autoimmune diseases, as well as outline some of the challenges that lie ahead.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
Self-citationAtkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175
Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Zhu, C., Anderson, A. C., Schubart, A., Xiong, H., Imitola, J., Khoury, S. J., Zheng, X. X., Strom, T. B., & Kuchroo, V. K. (2005) · Nature Immunology · doi:10.1038/ni1271 · Cited by 2,057
T follicular helper cell differentiation, function, and roles in disease
Crotty, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.004 · Cited by 1,847
Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,732
Bretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,692
Kuchroo, V. K., Prabhu Das, M., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., & Glimcher, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90349-6 · Cited by 1,641
Mueller, D. L., Jenkins, M. K., & Schwartz, R. H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002305 · Cited by 1,493
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,472
Role of LAG-3 in Regulatory T Cells
Huang, C.-T., Workman, C. J., Flies, D., Pan, X., Marson, A. L., Zhou, G., Hipkiss, E. L., Ravi, S., Kowalski, J., Levitsky, H. I., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.010 · Cited by 1,325
Self-citationPD-1 and PD-1 ligands: from discovery to clinical application
Okazaki, T., & Honjo, T. (2007) · International Immunology · doi:10.1093/intimm/dxm057 · Cited by 1,310
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition
Genovese, M. C., Becker, J.-C., Schiff, M., Luggen, M., Sherrer, Y., Kremer, J., Birbara, C., Box, J., Natarajan, K., Nuamah, I., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050524 · Cited by 1,241
ICOS co-stimulatory receptor is essential for T-cell activation and function
Dong, C., Juedes, A. E., Temann, U.-A., Shresta, S., Allison, J. P., Ruddle, N. H., & Flavell, R. A. (2001) · Nature · doi:10.1038/35051100 · Cited by 936
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., et al. (2003) · Nature Immunology · doi:10.1038/ni944 · Cited by 883
The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice
Ansari, M. J. I., Salama, A. D., Chitnis, T., Smith, R. N., Yagita, H., Akiba, H., Yamazaki, T., Azuma, M., Iwai, H., Khoury, S. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022125 · Cited by 814
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
Fife, B. T., Pauken, K. E., Eagar, T. N., Obu, T., Wu, J., Tang, Q., Azuma, M., Krummel, M. F., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1790 · Cited by 759
Lisnevskaia, L., Murphy, G., & Isenberg, D. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60128-8 · Cited by 752
Sánchez-Fueyo, A., Tian, J., Picarella, D., Domenig, C., Zheng, X. X., Sabatos, C. A., Manlongat, N., Bender, O., Kamradt, T., Kuchroo, V. K., et al. (2003) · Nature Immunology · doi:10.1038/ni987 · Cited by 712
Cellular and genetic mechanisms of self tolerance and autoimmunity
Goodnow, C. C., Sprent, J., de St Groth, B. F., & Vinuesa, C. G. (2005) · Nature · doi:10.1038/nature03724 · Cited by 699
Treatment of Murine Lupus with CTLA4Ig
Finck, B. K., Linsley, P. S., & Wofsy, D. (1994) · Science · doi:10.1126/science.7520604 · Cited by 668
Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses
Liang, S. C., Latchman, Y. E., Buhlmann, J. E., Tomczak, M. F., Horwitz, B. H., Freeman, G. J., & Sharpe, A. H. (2003) · European Journal of Immunology · doi:10.1002/eji.200324228 · Cited by 639
Latchman, Y. E., Liang, S. C., Wu, Y., Chernova, T., Sobel, R. A., Klemm, M., Kuchroo, V. K., Freeman, G. J., & Sharpe, A. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307252101 · Cited by 636
Sabatos, C. A., Chakravarti, S., Cha, E., Schubart, A., Sánchez-Fueyo, A., Zheng, X. X., Coyle, A. J., Strom, T. B., Freeman, G. J., & Kuchroo, V. K. (2003) · Nature Immunology · doi:10.1038/ni988 · Cited by 628
Boumpas, D. T., Furie, R., Manzi, S., Illei, G. G., Wallace, D. J., Balow, J. E., Vaishnaw, A., & on behalf of the BG9588 Lupus Nephritis Trial Group (2003) · Arthritis & Rheumatism · doi:10.1002/art.10856 · Cited by 618
Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C., & Bluestone, J. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1145 · Cited by 583
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Joller, N., Hafler, J. P., Brynedal, B., Kassam, N., Spoerl, S., Levin, S. D., Sharpe, A. H., & Kuchroo, V. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003081 · Cited by 581
Liang, B., Workman, C., Lee, J., Chew, C., Dale, B. M., Colonna, L., Flores, M., Li, N., Schweighoffer, E., Greenberg, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5916 · Cited by 566
Self-citationA NEW ANALYSIS OF ALLOGENEIC INTERACTIONS
Lafferty, K., & Cunningham, A. (1975) · Australian Journal of Experimental Biology and Medical Science · doi:10.1038/icb.1975.3 · Cited by 556
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Schildberg, F. A., Klein, S. R., Freeman, G. J., & Sharpe, A. H. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.002 · Cited by 542
Nishimura, H. (1998) · International Immunology · doi:10.1093/intimm/10.10.1563 · Cited by 500
CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.
Gerritse, K., Laman, J. D., Noelle, R. J., Aruffo, A., Ledbetter, J. A., Boersma, W. J., & Claassen, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2499 · Cited by 488
Acquisition of immunologic self-tolerance
Schwartz, R. H. (1989) · Cell · doi:10.1016/0092-8674(89)90044-5 · Cited by 477
Seki, M., Oomizu, S., Sakata, K.-M., Sakata, A., Arikawa, T., Watanabe, K., Ito, K., Takeshita, K., Niki, T., Saita, N., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.006 · Cited by 470
Targeting T Cell Co-receptors for Cancer Therapy
Callahan, M. K., Postow, M. A., & Wolchok, J. D. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.023 · Cited by 469
The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood
Sage, P. T., Francisco, L. M., Carman, C. V., & Sharpe, A. H. (2013) · Nature Immunology · doi:10.1038/ni.2496 · Cited by 467
B7h, a Novel Costimulatory Homolog of B7.1 and B7.2, Is Induced by TNFα
Swallow, M. M., Wallin, J. J., & Sha, W. C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80117-x · Cited by 453
Herman, A. E., Freeman, G. J., Mathis, D., & Benoist, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040179 · Cited by 450
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
Wang, J., Yoshida, T., Nakaki, F., Hiai, H., Okazaki, T., & Honjo, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505497102 · Cited by 437
Sage, P. T., Paterson, A. M., Lovitch, S. B., & Sharpe, A. H. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.005 · Cited by 437
B7S1, a Novel B7 Family Member that Negatively Regulates T Cell Activation
Prasad, D. V. R., Richards, S., Mai, X. M., & Dong, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00147-x · Cited by 431
CD40 Ligand-Dependent T Cell Activation: Requirement of B7-CD28 Signaling Through CD40
Yang, Y., & Wilson, J. M. (1996) · Science · doi:10.1126/science.273.5283.1862 · Cited by 427
Grewal, I. S., Foellmer, H. G., Grewal, K. D., Xu, J., Hardardottir, F., Baron, J. L., Janeway, C. A., & Flavell, R. A. (1996) · Science · doi:10.1126/science.273.5283.1864 · Cited by 418
Odegard, J. M., Marks, B. R., DiPlacido, L. D., Poholek, A. C., Kono, D. H., Dong, C., Flavell, R. A., & Craft, J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080840 · Cited by 418
Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3
Workman, C. J., Dugger, K. J., & Vignali, D. A. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5392 · Cited by 389
Self-citationMerrill, J. T., Burgos‐Vargas, R., Westhovens, R., Chalmers, A., D'Cruz, D., Wallace, D. J., Bae, S. C., Sigal, L., Becker, J. ‐., Kelly, S., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27601 · Cited by 376
CTLA-4: a negative regulator of autoimmune disease.
Karandikar, N. J., Vanderlugt, C. L., Walunas, T. L., Miller, S. D., & Bluestone, J. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.783 · Cited by 376
CD28/B7 Regulation of Th1 and Th2 Subsets in the Development of Autoimmune Diabetes
Lenschow, D. J., Herold, K. C., Rhee, L., Patel, B., Koons, A., Qin, H.-Y., Fuchs, E., Singh, B., Thompson, C. B., & Bluestone, J. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80323-4 · Cited by 374
Murine B7-H3 is a negative regulator of T cells
Prasad, D. V. R., Nguyen, T., Li, Z., Yang, Y., Duong, J., Wang, Y., & Dong, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2500 · Cited by 368 · cited 2×
“B7-H3 blockade resulted in enhanced EAE, whereas mice deficient in B7-H3 showed reduced disease severity and production of Th1 and Th17 cell cytokines (Luo et al., 2015; Prasad et al., 2004), suggesting that more analysis of this pathway is required.”
BackgroundVstm3 is a member of the CD28 family and an important modulator of T‐cell function
Levin, S. D., Taft, D. W., Brandt, C. S., Bucher, C., Howard, E. D., Chadwick, E. M., Johnston, J., Hammond, A., Bontadelli, K., Ardourel, D., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201041136 · Cited by 356
Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve‐Month, Randomized, Double‐Blind Study
Furie, R., Nicholls, K., Cheng, T., Houssiau, F., Burgos‐Vargas, R., Chen, S., Hillson, J. L., Meadows‐Shropshire, S., Kinaszczuk, M., & Merrill, J. T. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38260 · Cited by 341
Kalunian, K. C., Davis, J. C., Merrill, J. T., Totoritis, M. C., Wofsy, D., & for the IDEC‐131 Lupus Study Group (2002) · Arthritis & Rheumatism · doi:10.1002/art.10681 · Cited by 336
4-1BB-mediated immunotherapy of rheumatoid arthritis
Seo, S. K., Choi, J. H., Kim, Y. H., Kang, W. J., Park, H. Y., Suh, J. H., Choi, B. K., Vinay, D. S., & Kwon, B. S. (2004) · Nature Medicine · doi:10.1038/nm1107 · Cited by 325
Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE
Miller, S. D., Vanderlugt, C. L., Lenschow, D. J., Pope, J. G., Karandikar, N. J., Dal Canto, M. C., & Bluestone, J. A. (1995) · Immunity · doi:10.1016/1074-7613(95)90063-2 · Cited by 315
Emerging cell and cytokine targets in rheumatoid arthritis
Burmester, G. R., Feist, E., & Dörner, T. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.168 · Cited by 307
Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes
Lühder, F., Höglund, P., Allison, J. P., Benoist, C., & Mathis, D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.427 · Cited by 290
The ACCESS Trial Group (2014) · Arthritis & Rheumatology · doi:10.1002/art.38790 · Cited by 288
Bevaart, L., Vervoordeldonk, M. J., & Tak, P. P. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27503 · Cited by 253
Weinberg, A. D., Wegmann, K. W., Funatake, C., & Whitham, R. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1818 · Cited by 252
Balasa, B., Krahl, T., Patstone, G., Lee, J., Tisch, R., McDevitt, H. O., & Sarvetnick, N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.9.4620 · Cited by 244
Emery, P. E., Burmester, G. R., Bykerk, V. P., Combe, B. G., Fürst, D. E., Barré, E., Karyekar, C. S., Wong, D. A., & Huizinga, T. W. J. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206106 · Cited by 241
Webb, L. M. C., Walmsley, M. J., & Feldmann, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261008 · Cited by 239
Type 1 diabetes: translating mechanistic observations into effective clinical outcomes
Herold, K. C., Vignali, D. A. A., Cooke, A., & Bluestone, J. A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3422 · Cited by 237
Self-citationWan, B., Nie, H., Liu, A., Feng, G., He, D., Xu, R., Zhang, Q., Dong, C., & Zhang, J. Z. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8844 · Cited by 233
Self-citationOX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response
Jacquemin, C., Schmitt, N., Contin-Bordes, C., Liu, Y., Narayanan, P., Seneschal, J., Maurouard, T., Dougall, D., Davizon, E. S., Dumortier, H., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.012 · Cited by 233
Dysregulated T cell expression of TIM3 in multiple sclerosis
Koguchi, K., Anderson, D. E., Yang, L., O'Connor, K. C., Kuchroo, V. K., & Hafler, D. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060210 · Cited by 232
Perrin, P. J., Maldonado, J. H., Davis, T. A., June, C. H., & Racke, M. K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1333 · Cited by 226
Graham, D. S. C., Graham, R. R., Manku, H., Wong, A. K., Whittaker, J. C., Gaffney, P. M., Moser, K. L., Rioux, J. D., Altshuler, D., Behrens, T. W., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.47 · Cited by 222
Early, G. S., Zhao, W., & Burns, C. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.7.3159 · Cited by 218
Vijayakrishnan, L., Slavik, J. M., Illés, Z., Greenwald, R. J., Rainbow, D., Greve, B., Peterson, L. B., Hafler, D. A., Freeman, G. J., Sharpe, A. H., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00110-4 · Cited by 218
Daikh, D. I., Finck, B. K., Linsley, P. S., Hollenbaugh, D., & Wofsy, D. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3104 · Cited by 217
Howard, L. M., Miga, A. J., Vanderlugt, C. L., Canto, M. C. D., Laman, J. D., Noelle, R. J., & Miller, S. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5388 · Cited by 217
Chang, T. T., Jabs, C., Sobel, R. A., Kuchroo, V. K., & Sharpe, A. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.733 · Cited by 215
Becher, B., Durell, B. G., Miga, A. V., Hickey, W. F., & Noelle, R. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.967 · Cited by 213
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity
Paterson, A. M., Lovitch, S. B., Sage, P. T., Juneja, V. R., Lee, Y., Trombley, J. D., Arancibia-Cárcamo, C. V., Sobel, R. A., Rudensky, A. Y., Kuchroo, V. K., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141030 · Cited by 212
Orban, T., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Marks, J. B., Monzavi, R., et al. (2014) · Diabetes Care · doi:10.2337/dc13-0604 · Cited by 209
Khoury, S. J., Akalin, E., Chandraker, A., Turka, L. A., Linsley, P. S., Sayegh, M. H., & Hancock, W. W. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4521 · Cited by 202
The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo
Paterson, A. M., Brown, K. E., Keir, M. E., Vanguri, V. K., Riella, L. V., Chandraker, A., Sayegh, M. H., Blazar, B. R., Freeman, G. J., & Sharpe, A. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003496 · Cited by 202
Expansion of Autoreactive T Cells in Multiple Sclerosis Is Independent of Exogenous B7 Costimulation
Scholz, C., Patton, K. T., Anderson, D. E., Freeman, G. J., & Hafler, D. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1532 · Cited by 194
Racke, M. K., Scott, D. E., Quigley, L., Gray, G. S., Abe, R., June, C. H., & Perrin, P. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118274 · Cited by 192
Raptopoulou, A. P., Bertsias, G., Makrygiannakis, D., Verginis, P., Kritikos, I., Tzardi, M., Klareskog, L., Catrina, A. I., Sidiropoulos, P., & Boumpas, D. T. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27500 · Cited by 191
Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis
Dong, H., Strome, S. E., Matteson, E. L., Moder, K. G., Flies, D. B., Zhu, G., Tamura, H., Driscoll, C. L. W., & Chen, L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16015 · Cited by 190
Sun, Y., Lin, X., Chen, H. M., Wu, Q., Subudhi, S. K., Chen, L., & Fu, Y.-X. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1457 · Cited by 189
Carter, L. L., Leach, M. W., Azoitei, M. L., Cui, J., Pelker, J. W., Jussif, J., Benoit, S., Ireland, G., Luxenberg, D., Askew, G. R., et al. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.10.006 · Cited by 183
Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease
Sun, Y., Chen, H. M., Subudhi, S. K., Chen, J., Koka, R., Chen, L., & Fu, Y.-X. (2002) · Nature Medicine · doi:10.1038/nm1202-796 · Cited by 181
Defective Central Tolerance Induction in NOD Mice: Genomics and Genetics
Zucchelli, S., Holler, P., Yamagata, T., Roy, M., Benoist, C., & Mathis, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.015 · Cited by 178
Foell, J. L., Strahotin, S., O’Neil, S. P., McCausland, M. M., Suwyn, C. R., Haber, M., Chander, P. N., Bapat, A. S., Yan, X., Chiorazzi, N., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17662 · Cited by 176
Kornete, M., Sgouroudis, E., & Piccirillo, C. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101303 · Cited by 170
Cutting Edge: Accelerated Autoimmune Diabetes in the Absence of LAG-3
Bettini, M., Szymczak-Workman, A. L., Forbes, K., Castellaw, A. H., Selby, M., Pan, X., Drake, C. G., Korman, A. J., & Vignali, D. A. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100714 · Cited by 169
Self-citationFunctional CD40 ligand is expressed by T cells in rheumatoid arthritis.
MacDonald, K. P., Nishioka, Y., Lipsky, P. E., & Thomas, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119781 · Cited by 168
Lyons, P. A., Hancock, W. W., Denny, P., Lord, C. J., Hill, N. J., Armitage, N., Siegmund, T., Todd, J. A., Phillips, M. S., Hess, J. F., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00012-1 · Cited by 166
CTLA4Ig inhibits T cell–dependent B-cell maturation in murine systemic lupus erythematosus
Mihara, M., Tan, I., Chuzhin, Y., Reddy, B., Budhai, L., Holzer, A., Gu, Y., & Davidson, A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9244 · Cited by 166
Kageyama, R., Cannons, J. L., Zhao, F., Yusuf, I., Lao, C., Locci, M., Schwartzberg, P. L., & Crotty, S. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.016 · Cited by 162
Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig.
Knoerzer, D. B., Karr, R. W., Schwartz, B. D., & Mengle-Gaw, L. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118146 · Cited by 161
Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection
Subudhi, S. K., Zhou, P., Yerian, L. M., Chin, R. K., Lo, J. C., Anders, R. A., Sun, Y., Chen, L., Wang, Y., Alegre, M.-L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19210 · Cited by 161
Magnus, T., Schreiner, B., Korn, T., Jack, C., Guo, H., Antel, J., Ifergan, I., Chen, L., Bischof, F., Bar-Or, A., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4794-04.2005 · Cited by 160
Targeting co-stimulatory pathways: transplantation and autoimmunity
Ford, M. L., Adams, A. B., & Pearson, T. C. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.183 · Cited by 159
Cribbs, A. P., Kennedy, A., Penn, H., Read, J. E., Amjadi, P., Green, P., Syed, K., Manka, S. W., Brennan, F. M., Gregory, B., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38715 · Cited by 158
Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells
Bour-Jordan, H., Salomon, B. L., Thompson, H. L., Szot, G. L., Bernhard, M. R., & Bluestone, J. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20483 · Cited by 157
Weinberg, A. D., BOURDETTE, D. N., Sullivan, T. J., Lemon, M., Wallin, J. J., Maziarz, R. T., Davey, M. P., Palida, F., Godfrey, W. R., Engleman, E. G., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-183 · Cited by 156
B7RP-1 Blockade Ameliorates Autoimmunity through Regulation of Follicular Helper T Cells
Hu, Y., Metz, D. P., Chung, J. B., Siu, G., & Zhang, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1421 · Cited by 147
Iwai, H., Kozono, Y., Hirose, S., Akiba, H., Yagita∥, H., Okumura, K., Kohsaka, H., Miyasaka, N., & Azuma, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4332 · Cited by 142
Lack of TIM-3 Immunoregulation in Multiple Sclerosis
Yang, L., Anderson, D. E., Kuchroo, J. R., & Hafler, D. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4409 · Cited by 142
O’Neill, S. K., Cao, Y., Hamel, K. M., Doodes, P. D., Hutás, G., & Finnegan, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5109 · Cited by 128
Wicker, L. S., Chamberlain, G., Hunter, K. M. D., Rainbow, D. B., Howlett, S., Tiffen, P. G., Clark, J., González-Muñoz, A., Cumiskey, A. M., Rosa, R. L., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.164 · Cited by 126
Boon, L., Brok, H., Bauer, J., Ortiz-Buijsse, A., Schellekens, M. M., Ramdien‐Murli, S., Blezer, E. L. A., van Meurs, M., Ceuppens, J. L., de Boer, M., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2942 · Cited by 119
Nohara, C., Akiba, H., Nakajima, A., Inoue, A., Koh, C., Ohshima, H., Yagita∥, H., Mizuno, Y., & Okumura, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.2108 · Cited by 116
Luo, L., Zhu, G., Xu, H., Yao, S., Zhou, G., Zhu, Y., Tamada, K., Huang, L., Flies, A. S., Broadwater, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130126 · Cited by 115
Zhu, B., Guleria, I., Khosroshahi, A., Chitnis, T., Imitola, J., Azuma, M., Yagita∥, H., Sayegh, M. H., & Khoury, S. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3480 · Cited by 114
Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells
Lühder, F., Chambers, C. A., Allison, J. P., Benoist, C. O., & Mathis, D. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200348397 · Cited by 112
Hurwitz, A. A., Sullivan, T. J., Krummel, M. F., Sobel, R. A., & Allison, J. P. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00168-3 · Cited by 110
Ndhlovu, L. C., Ishii, N., Murata, K., Sato, T., & Sugamura, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2991 · Cited by 109
Coquet, J. M., Middendorp, S., Horst, G., Kind, J., Veraar, E. A. M., Xiao, Y., Jacobs, H., & Borst, J. G. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.009 · Cited by 109
Dahlén, E., Hedlund, G., & Dawe, K. I. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2444 · Cited by 104
PD‐1 ligands expressed on myeloid‐derived APC in the CNS regulate T‐cell responses in EAE
Schreiner, B., Bailey, S. L., Shin, T., Chen, L., & Miller, S. D. (2008) · European Journal of Immunology · doi:10.1002/eji.200838137 · Cited by 104
CD28-Deficient Mice Are Highly Resistant to Collagen-Induced Arthritis
Tada, Y., Nagasawa, K., Ho, A., Morito, F., Ushiyama, O., Suzuki, N., Ohta, H., & Mak, T. W. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.203 · Cited by 97
Protective Role of Programmed Death 1 Ligand 1 (PD-L1)in Nonobese Diabetic Mice
Wang, C.-J., Chou, F., Chu, C.-H., Wu, J., Lin, S., Chang, D., & Sytwu, H. (2008) · Diabetes · doi:10.2337/db07-1260 · Cited by 96
Effects of anti‐CD154 treatment on B cells in murine systemic lupus erythematosus
Wang, X., Huang, W., Schiffer, L. E., Mihara, M., Akkerman, A., Hiromatsu, K., & Davidson, A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10929 · Cited by 95
Thinking bedside at the bench: the NOD mouse model of T1DM
Reed, J. C., & Herold, K. C. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.236 · Cited by 94
Role of glucocorticoid‐induced TNF receptor family gene (GITR) in collagen‐induced arthritis
Cuzzocrea, S., Ayroldi, E., Paola, R. D., Agostini, M., Mazzon, E., Bruscoli, S., Genovese, T., Ronchetti, S., Caputi, A. P., & Riccardi, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-3556com · Cited by 94
Ma, J., Xu, J., Madaio, M. P., Peng, Q., Zhang, J., Grewal, I. S., Flavell, R. A., & Craft, J. E. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.417 · Cited by 91
Kasagi, S., Kawano, S., Okazaki, T., Honjo, T., Morinobu, A., Hatachi, S., Shimatani, K., Tanaka, Y., Minato, N., & Kumagai, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901652 · Cited by 87
Ko, H.-J., Cho, M., Lee, S.-Y., Oh, H., Heo, Y., Moon, Y., Kang, C., Kwok, S., Ju, J. H., Park, S., et al. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.07.006 · Cited by 84
Araki, M., Chung, D., Liu, S. M., Rainbow, D. B., Chamberlain, G., Garner, V. E. S., Hunter, K. M. D., Vijayakrishnan, L., Peterson, L. B., Oukka, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802610 · Cited by 84
Crampton, S. P., Morawski, P. A., & Bolland, S. M. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016451 · Cited by 84
CD28 Costimulation Is Crucial for the Development of Spontaneous Autoimmune Encephalomyelitis
Oliveira-dos-Santos, A., Ho, A., Tada, Y., Lafaille, J. J., Tonegawa, S., Mak, T. W., & Penninger, J. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4490 · Cited by 81
ICOS Ligand Costimulation Is Required for T-Cell Encephalitogenicity
Sporici, R. A., Beswick, R. L., von Allmen, C., Rumbley, C. A., Hayden-Ledbetter, M. S., Ledbetter, J. A., & Perrin, P. J. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5074 · Cited by 80
Hurwitz, A. A., Sullivan, T. J., Sobel, R. A., & Allison, J. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042684699 · Cited by 79
CD28-independent induction of experimental autoimmune encephalomyelitis
Chitnis, T., Najafian, N., Abdallah, K. A., Dong, V. M., Yagita∥, H., Sayegh, M. H., & Khoury, S. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11220 · Cited by 76
Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist
Fife, B. T., Griffin, M. D., Abbas, A. K., Locksley, R. M., & Bluestone, J. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27856 · Cited by 74
Wong, M., Cava, A. L., & Hahn, B. H. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202382 · Cited by 73
Green, E. A., Wong, F. S., Eshima, K., Mora, C., & Flavell, R. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.225 · Cited by 71
Elyaman, W., Kivisäkk, P., Reddy, J., Chitnis, T., Raddassi, K., Imitola, J., Bradshaw, E., Kuchroo, V., Yagita, H., Sayegh, M., et al. (2008) · American Journal of Pathology · doi:10.2353/ajpath.2008.080142 · Cited by 67
Lessons from animal models of arthritis over the past decade
Berg, W. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2803 · Cited by 67
Tran, C. N., Thacker, S. G., Louie, D. M., Oliver, J. A., White, P. T., Endres, J., Urquhart, A. G., Chung, K. C., & Fox, D. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2989 · Cited by 66
Bodhankar, S., Galipeau, D., Vandenbark, A. A., & Offner, H. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000143 · Cited by 66
Karandikar, N. J., Vanderlugt, C. L., Eagar, T. N., Tan, L., Bluestone, J. A., & Miller, S. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.192 · Cited by 66
The soluble CTLA-4 receptor and its role in autoimmune diseases: an update
Saverino, D., Simone, R., Bagnasco, M., & Pesce, G. (2010) · Autoimmunity Highlights · doi:10.1007/s13317-010-0011-7 · Cited by 65
Carboni, S., Aboul‐Enein, F., Waltzinger, C., Killeen, N. P., Lassmann, H., & Rossi, C. P. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.07.001 · Cited by 64
Laman, J. D., Hart, B. A. ‘., Brok, H., van Meurs, M., Schellekens, M. M., Kasran, A., Boon, L., Bauer, J., de Boer, M., & Ceuppens, J. L. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200208)32:8<2218::aid-immu2218>3.0.co;2-0 · Cited by 64
Kornete, M., Mason, E. S., Girouard, J., Lafferty, E. I., Qureshi, S. T., & Piccirillo, C. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126311 · Cited by 60
Liang, B., Gee, R. J., Kashgarian, M. J., Sharpe, A. H., & Mamula, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2322 · Cited by 58
Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice
Ansari, M. J., Fiorina, P., Dada, S., Guleria, I., Ueno, T., Yuan, X., Trikudanathan, S., Smith, R. N., Freeman, G. J., & Sayegh, M. H. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.07.019 · Cited by 58
Involvement of CD70–CD27 interactions in the induction of experimental autoimmune encephalomyelitis
Nakajima, A., Oshima, H., Nohara, C., Morimoto, S., Yoshino, S., Kobata, T., Yagita∥, H., & Okumura, K. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00324-6 · Cited by 58
B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms
Podojil, J. R., Liu, L. N., Marshall, S. A., Chiang, M.-Y., Goings, G. E., Chen, L., Langermann, S., & Miller, S. D. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.04.001 · Cited by 57
Trans-Ancestral Studies Fine Map the SLE-Susceptibility Locus TNFSF4
Manku, H., Langefeld, C. D., Guerra, S. G., Malik, T. H., Alarcón-Riquelme, M. E., Anaya, J., Bae, S., Boackle, S. A., Brown, E. E., Criswell, L. A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003554 · Cited by 57
Verhagen, J., Genolet, R., Britton, G. J., Stevenson, B. J., Sabatos-Peyton, C. A., Dyson, J., Luescher, I. F., & Wraith, D. C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208573110 · Cited by 57
Modulating Protective and Pathogenic CD4+ Subsets via CD137 in Type 1 Diabetes
Irie, J., Wu, Y., Kachapati, K., Mittler, R. S., & Ridgway, W. M. (2006) · Diabetes · doi:10.2337/db06-0793 · Cited by 57
Karandikar, N. J., Eagar, T. N., Vanderlugt, C. L., Bluestone, J. A., & Miller, S. D. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00322-2 · Cited by 55
CD40 on NOD CD4 T cells contributes to their activation and pathogenicity
Baker, R. L., Wagner, D. H., & HASKINS, K. M. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.09.001 · Cited by 55
Cannons, J. L., Chamberlain, G., Howson, J. M. M., Smink, L. J., Todd, J. A., Peterson, L. B., Wicker, L. S., & Watts, T. H. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.04.007 · Cited by 54
Early Treatment of NOD Mice With B7-H4 Reduces the Incidence of Autoimmune Diabetes
Wang, X., Hao, J., Metzger, D. L., Mui, A., Ao, Z., Akhoundsadegh, N., Langermann, S., Liu, L. L., Chen, L., Ou, D., et al. (2011) · Diabetes · doi:10.2337/db11-0375 · Cited by 54
ICOS Mediates the Development of Insulin-Dependent Diabetes Mellitus in Nonobese Diabetic Mice
Hawiger, D., Tran, E., Du, W., Booth, C. J., Li, W., Dong, C., & Flavell, R. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3140 · Cited by 53
Kim, Y. H., Choi, B. K., Shin, S. M., Kim, C. H., Oh, H. S., Park, S. H., Lee, D. G., Lee, M. J., Kim, K. H., Vinay, D. S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002681 · Cited by 53
Verhagen, J., Gabryšová, L., Minaee, S., Sabatos, C. A., Anderson, G., Sharpe, A. H., & Wraith, D. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803186106 · Cited by 52
Local Triggering of the ICOS Coreceptor by CD11c+ Myeloid Cells Drives Organ Inflammation in Lupus
Teichmann, L. L., Cullen, J. L., Kashgarian, M. J., Dong, C., Craft, J. E., & Shlomchik, M. J. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.015 · Cited by 50
CD28/CTLA‐4/B7 costimulatory pathway blockade affects regulatory T‐cell function in autoimmunity
Vogel, I., Kasran, A., Cremer, J., Kim, Y., Boon, L., Gool, S. W. V., & Ceuppens, J. L. (2015) · European Journal of Immunology · doi:10.1002/eji.201445190 · Cited by 48
Perrin, P. J., Scott, D. E., Davis, T. A., Gray, G. S., Doggett, M. J., Abe, R., June, C. H., & Racke, M. K. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00172-7 · Cited by 47
SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells
Chatterjee, M., Kis‐Tóth, K., Thai, T., Terhorst, C., & Tsokos, G. C. (2011) · Autoimmunity · doi:10.3109/08916934.2010.530627 · Cited by 44
Wong, M., Cava, A. L., Singh, R. P., & Hahn, B. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903401 · Cited by 44
OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis
Findlay, E. G., Danks, L., Madden, J., Cavanagh, M., McNamee, K., McCann, F. E., Snelgrove, R. J., Shaw, S., Feldmann, M., Taylor, P. C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321071111 · Cited by 44
Amrani, A., Serra, P., Yamanouchi, J., Han, B., Thiessen, S., Verdaguer, J., & Santamaría, P. (2002) · Immunity · doi:10.1016/s1074-7613(02)00315-1 · Cited by 43
Haanstra, K. G., Dijkman, K., Bashir, N., Bauer, J., Mary, C., Poirier, N., Baker, P., Scobie, L., Hart, B. A. ‘., & Vanhove, B. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402563 · Cited by 43
ICOS Deficiency Results in Exacerbated IL-17 Mediated Experimental Autoimmune Encephalomyelitis
Galicia, G., Kasran, A., Uyttenhove, C., Swert, K. D., Snick, J. V., & Ceuppens, J. L. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9287-7 · Cited by 42
The B7-Independent Isoform of CTLA-4 Functions To Regulate Autoimmune Diabetes
Stumpf, M., Zhou, X., & Bluestone, J. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201362 · Cited by 41
Preclinical assessment of anti-CD40 Mab 5D12 in cynomolgus monkeys
Boon, L., Laman, J. D., Ortiz-Buijsse, A., den Hartog, M. T., Hoffenberg, S., Liu, P., Shiau, F. Y., & de Boer, M. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00057-4 · Cited by 40
Kachapati, K., Adams, D. E., Wu, Y., Steward, C. A., Rainbow, D. B., Wicker, L. S., Mittler, R. S., & Ridgway, W. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101013 · Cited by 40
Paradoxical Dampening of Anti-Islet Self-Reactivity but Promotion of Diabetes by OX40 Ligand
Martín‐Orozco, N., Chen, Z., Poirot, L., Hyatt, E., Chen, A., Kanagawa, O., Sharpe, A. H., Mathis, D. J., & Benoist, C. O. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6954 · Cited by 40
Gómez, J. M. M., Croxford, J. L., Yeo, K. P., Angéli, V., Schwarz, H., & Gasser, S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2473-12.2012 · Cited by 39
Cutting Edge: An NK Cell-Independent Role for Slamf4 in Controlling Humoral Autoimmunity
Brown, D. R., Calpe, S., Keszei, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100510 · Cited by 39
Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice
Kachapati, K., Bednar, K. J., Adams, D. E., Wu, Y., Mittler, R. S., Jordan, M. B., Hinerman, J. M., Herr, A. B., & Ridgway, W. M. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.09.002 · Cited by 38
de Oliveira, E. M. L., Bar‐Or, A., Waliszewska, A. I., Cai, G., Anderson, D. E., Krieger, J. I., & Hafler, D. A. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(02)00106-3 · Cited by 35
Sytwu, H., Lin, W., Roffler, S. R., Hung, J., Sung, H.-S., Wang, C., Cheng, T., Tsou, S.-C., Hsi, S., & Shen, K. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00112-4 · Cited by 33
Pierer, M., Schulz, A., Rossol, M., Kendzia, E., Kyburz, D., Haentzschel, H., Baerwald, C., & Wagner, U. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0713715 · Cited by 32
Oya, Y., Watanabe, N., Kobayashi, Y., Owada, T., Oki, M., Ikeda, K., Suto, A., Kagami, S., Hirose, K., Kishimoto, T., et al. (2011) · International Immunology · doi:10.1093/intimm/dxr017 · Cited by 31
CTLA-4 Gene Polymorphism and the Risk of Systemic Lupus Erythematosus in the Chinese Population
Khalaf, A. T., Song, J., Gao, T., Yu, X.-P., & Lei, T. (2011) · BioMed Research International · doi:10.1155/2011/167395 · Cited by 25
The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis
Koh, A. E., Njoroge, S. W., Feliu, M., Cook, A., Selig, M. K., Latchman, Y. E., Sharpe, A. H., Colvin, R. B., & Paul, E. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.03.004 · Cited by 24
Kotani, M., Hirata, K., Ogawa, S., Habiro, K., Ishida, Y., Tanuma, S.-I., Horai, R., Iwakura, Y., Kishimoto, H., & Abe, R. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21769 · Cited by 11
Activation of the Ras-related GTPase Rap1 by thymocyte TCR engagement and during selection
(2000) · Pure Amsterdam UMC · doi:10.1002/1521-4141(200010)30:10 · Cited by 3
Cited by
Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
CD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Lin, Y.-J., Anzaghe, M., & Schülke, S. (2020) · Cells · doi:10.3390/cells9040880 · Cited by 932
The Balance of Th17 versus Treg Cells in Autoimmunity
Lee, G. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030730 · Cited by 857
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
Auslander, N., Zhang, G., Lee, J. S., Frederick, D. T., Miao, B., Moll, T., Tian, T., Wei, Z., Madan, S., Sullivan, R. J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0157-9 · Cited by 738
Metadata
- Authors
- Zhang, Q., & Vignali, D. A. A.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 44
- Issue
- 5
- Pages
- 1034-1051
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2398619572
- Cited by
- 296
- References
- 186
- FWCI
- 15.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.